Literature DB >> 7805198

Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat.

C H Conrad1, W W Brooks, J A Hayes, S Sen, K G Robinson, O H Bing.   

Abstract

BACKGROUND: Fibrosis is commonly found in association with cardiac hypertrophy and failure, but the relation of the connective tissue response to the development of impaired cardiac function remains unclear. We examined passive myocardial stiffness, active contractile function, and fibrosis in the spontaneously hypertensive rat (SHR), a model of chronic pressure overload in which impaired cardiac function follows a long period of stable hypertrophy. METHODS AND
RESULTS: We studied the passive and active mechanical properties of left ventricular (LV) papillary muscles isolated from normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR) at the ages of 12 months and 20 to 23 months. Seven of 15 SHR between 20 and 23 months of age had findings consistent with heart failure (SHR-F). In comparison to preparations from WKY rats and nonfailing SHR (SHR-NF), papillary muscles from the SHR-F group demonstrated increased passive stiffness (central segment exponential stiffness constant, kcs: SHR-F 95.6 +/- 19.8, SHR-NF 42.1 +/- 9.7, WKY rats 39.5 +/- 9.5 (mean +/- SD); SHR-F P < .01 versus SHR-NF, WKY rats). The increase in stiffness was associated with an increase in LV collagen concentration (SHR-F 8.71 +/- 3.14, SHR-NF 5.83 +/- 1.20, WKY rats 4.78 +/- 0.70 mg hydroxyproline/g dry LV wt; SHR-F P < .01 versus SHR-NF, WKY rats); an increase in interstitial fibrosis, as determined histologically (SHR-F 13.5 +/- 8.0%, SHR-NF 4.9 +/- 2.1%, WKY rats 3.6 +/- 0.8%; SHR-F P < .01 versus SHR-NF, WKY rats); and impaired tension development (SHR-F 3.18 +/- 1.27, SHR-NF 4.41 +/- 1.04, WKY rats 4.64 +/- 0.85 kdyne/mm2; SHR-F P < .05 versus SHR-NF; P < .01 versus WKY rats).
CONCLUSIONS: The development of heart failure in the aging SHR is associated with marked myocardial fibrosis, increased passive stiffness, and impaired contractile function relative to age-matched nonfailing SHR and nonhypertensive control animals. These data suggest that fibrosis or events underlying the connective tissue response are important in the transition from compensated hypertrophy to failure in the SHR.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805198     DOI: 10.1161/01.cir.91.1.161

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  119 in total

Review 1.  The extracellular matrix in normal and diseased myocardium.

Authors:  S Hein; J Schaper
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  Matrix elasticity regulates the optimal cardiac myocyte shape for contractility.

Authors:  Megan L McCain; Hongyan Yuan; Francesco S Pasqualini; Patrick H Campbell; Kevin Kit Parker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-28       Impact factor: 4.733

3.  Effect of chronic colchicine administration on the myocardium of the aging spontaneously hypertensive rat.

Authors:  A C Cicogna; W W Brooks; J A Hayes; K G Robinson; S Sen; C H Conrad; O H Bing
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

4.  Remodeling of the transverse tubular system after myocardial infarction in rabbit correlates with local fibrosis: A potential role of biomechanics.

Authors:  T Seidel; A C Sankarankutty; F B Sachse
Journal:  Prog Biophys Mol Biol       Date:  2017-07-11       Impact factor: 3.667

5.  Enhanced Ca(2+)-induced Ca(2+) release from intracellular stores contributes to catecholamine hypersecretion in adrenal chromaffin cells from spontaneously hypertensive rats.

Authors:  Pedro Segura-Chama; Patricia López-Bistrain; Elia Martha Pérez-Armendáriz; Nicolás Jiménez-Pérez; Diana Millán-Aldaco; Arturo Hernández-Cruz
Journal:  Pflugers Arch       Date:  2015-03-21       Impact factor: 3.657

6.  Loss of dystrophin is associated with increased myocardial stiffness in a model of left ventricular hypertrophy.

Authors:  Martín Donato; Bruno Buchholz; Celina Morales; Laura Valdez; Tamara Zaobornyj; Sergio Baratta; Diamela T Paez; Mirian Matoso; Guillermo Vaccarino; Demian Chejtman; Oscar Agüero; Juan Telayna; José Navia; Alejandro Hita; Alberto Boveris; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

7.  Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  Will Soesanto; Han-Yi Lin; Eric Hu; Shane Lefler; Sheldon E Litwin; Sandra Sena; E Dale Abel; J David Symons; Thunder Jalili
Journal:  Hypertension       Date:  2009-11-02       Impact factor: 10.190

8.  Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study.

Authors:  Sirisha Donekal; Bharath A Venkatesh; Yuan Chang Liu; Chia-Ying Liu; Kihei Yoneyama; Colin O Wu; Marcelo Nacif; Antoinette S Gomes; W Gregory Hundley; David A Bluemke; Joao A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2014-02-18       Impact factor: 7.792

9.  Myostatin and follistatin expression in skeletal muscles of rats with chronic heart failure.

Authors:  Aline Regina Ruiz Lima; Paula Felippe Martinez; Katashi Okoshi; Daniele Mendes Guizoni; Leonardo A Mamede Zornoff; Dijon Henrique Salomé Campos; Sílvio Assis Oliveira; Camila Bonomo; Maeli Dal Pai-Silva; Marina Politi Okoshi
Journal:  Int J Exp Pathol       Date:  2009-12-03       Impact factor: 1.925

Review 10.  Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling.

Authors:  Nethika R Ariyasinghe; Davi M Lyra-Leite; Megan L McCain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.